下一代元基因组测序用于诊断神经菌病
1Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Future microbiology
|April 17, 2024
概括
大脑脊髓液 (CSF) 的下一代元基因组测序 (mNGS) 提供了对神经骨髓瘤 (NB) 的卓越诊断灵敏度. 在怀疑NB病例时,建议在使用抗生素之前进行早期的CSF mNGS测试.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 基因组学就是基因组学.
背景情况:
- 神经结核病 (NB) 是一种严重的感染,影响神经系统.
- 准确及时诊断NB对于有效治疗至关重要.
研究的目的:
- 为了评估神经菌病的元基因组下一代测序 (mNGS) 的诊断性能.
- 为了将mNGS与NB的传统诊断方法进行比较.
主要方法:
- 对被诊断患有NB的患者的回顾性分析.
- 脑脊液 (CSF) 的样本使用mNGS进行了测试.
- 与血清孟加拉试验,血清凝结试验和CSF培养结果进行比较.
主要成果:
- 在20名患者中,CSF mNGS在18名患者中检测到NB (90%的灵敏度).
- 传统测试显示灵敏度较低:脑液培养 (6/11,54.5%),血清孟加拉 (11/16,68.8%),血清凝结 (13/16,81.3%).
- 与传统方法相比,mNGS表现出明显更高的灵敏度.
结论:
- 脑脊液mNGS是一种高度敏感的诊断神经结核病的方法.
- 建议在怀疑NB的抗生素治疗开始之前进行CSF mNGS测试.
相关概念视频
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...


